Collection, analysis and transplantation of Ph-negative blood precursor cells in chronic myeloid leukemia

Leukemia

Volumn 10, Issue SUPPL. 2, 1996, Pages

  Frassoni, F ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Autografting; Chronic myeloid leukemia; Ph negative cells

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN;

ARTICLE; AUTOTRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; HUMAN; LEUKAPHERESIS; MULTIMODALITY CANCER THERAPY; MYELOID LEUKEMIA; RECURRENT DISEASE; REMISSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IDARUBICIN; LEUKAPHERESIS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; RECURRENCE; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0005132456     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Talpaz M, Kantarjian HM, McCredie KB et al. Hematologic remission and cytogenetic improvement induced by recombinant human interferon-alpha in chronic myelogenous leukemia. New Engl J Med 1986; 314: 1065-1069.
2. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon 2-alpha as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New Engl J Med 1994; 330: 820-825.